116 related articles for article (PubMed ID: 179361)
1. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
Stefano S; Kerman R; Abbate J
AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
[TBL] [Abstract][Full Text] [Related]
2. An immunological outcome predictive score for head and neck carcinoma patients.
Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
[TBL] [Abstract][Full Text] [Related]
3. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
6. Immune defects in patients with head and neck cancer.
Wustrow TP; Issing WJ
Anticancer Res; 1993; 13(6B):2507-19. PubMed ID: 8135491
[TBL] [Abstract][Full Text] [Related]
7. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
Rabin BS; Johnson J; Claassen D
Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
[TBL] [Abstract][Full Text] [Related]
8. The treatment of patients with stage IV squamous cell carcinoma of the head and neck: a primary radiation therapy experience in 184 cases.
Ucmakli A
Otolaryngol Clin North Am; 1980; 13(3):529-32. PubMed ID: 7443241
[No Abstract] [Full Text] [Related]
9. A study of T-lymphocytes and delayed cutaneous hypersensitivity reaction in patients with squamous cell carcinoma of head and neck region.
Singh SN; Agrawal BM; Shanker R; Rajvanshi VS
Indian J Cancer; 1979; 16(3-4):53-8. PubMed ID: 317272
[No Abstract] [Full Text] [Related]
10. Cellular immunity in patients with epidermoid cancer of the head and neck.
Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
[TBL] [Abstract][Full Text] [Related]
11. Unique immunobiological aspects of head and neck squamous carcinoma.
Chretien PB
Can J Otolaryngol; 1975; 4(2):225-35. PubMed ID: 166742
[TBL] [Abstract][Full Text] [Related]
12. T-cell deficiency in patients with squamous cell cancer of the head and neck.
Wanebo HJ; Jun MY; Strong EW; Oettgen H
Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
[TBL] [Abstract][Full Text] [Related]
13. Cellular immune profile and T-lymphocyte blocking factors in cancer of the head and neck and their prognostic significance.
Sinha R; Gupta SC; Naithani YP
Indian J Cancer; 1985 Mar; 22(1):8-16. PubMed ID: 3879757
[No Abstract] [Full Text] [Related]
14. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
Maisel RH; Ogura JH
Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
[TBL] [Abstract][Full Text] [Related]
15. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome.
Chen AM; Chen LM; Vaughan A; Sreeraman R; Farwell DG; Luu Q; Lau DH; Stuart K; Purdy JA; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):414-9. PubMed ID: 20399030
[TBL] [Abstract][Full Text] [Related]
16. Transference of cell mediated immunity in patients with head and neck cancer.
Vetto RM; Burger DR
Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
[TBL] [Abstract][Full Text] [Related]
18. Controlled trial of methotrexate and Bacillus Calmette-Guérin therapy for advanced head and neck cancer.
Papac R; Minor DR; Rudnick S; Solomon LR; Capizzi RL
Cancer Res; 1978 Oct; 38(10):3150-3. PubMed ID: 356962
[TBL] [Abstract][Full Text] [Related]
19. [The immunological prognosis of complications in patients undergoing reconstructive operations after the radiation therapy of malignant tumors of the maxillofacial area and neck].
Trufanov VD; Boĭkov AN; Simonova AV; Zandelov VL; Kulakov AV
Stomatologiia (Mosk); 1991; (6):35-7. PubMed ID: 1803649
[TBL] [Abstract][Full Text] [Related]
20. Immunological status of patients in carcinoma head and neck.
Vasenwala SM; Aziz M; Rattan A; Ahmad KN
Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
